Journal article icon

Journal article

Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression

Abstract:
Interaction between the tumor microenvironment and cancer cell plasticity drives intratumor phenotypic heterogeneity and underpins disease progression and nongenetic therapy resistance. Phenotype-specific expression of the AXL receptor tyrosine kinase is a pivotal player in dormancy, invasion, and resistance to treatment. However, although the AXL ligand GAS6 is present within tumors, how AXL is activated in metastasizing cells remains unclear. Here, using melanoma as a model, we reveal that AXL is activated by exposure to human adipocytes and to oleic acid, a monounsaturated fatty acid abundant in lymph and in adipocytes. AXL activation triggers SRC-dependent formation and nuclear translocation of a β-catenin-CAV1 complex required for melanoma invasiveness. Remarkably, only undifferentiated AXLHigh melanoma cells engage in symbiosis with human adipocytes, in part by triggering WNT5a-mediated lipolysis, leading to AXL-dependent, but FATP-independent, fatty acid uptake and nuclear localization of the β-catenin-CAV1 complex. Significantly, human melanomas in the vicinity of adipocytes exhibit high levels of nuclear CAV1. The results unveil an AXL- and CAV1-dependent mechanism through which a nutritional input drives phenotype-specific activation of a prometastasis program. Given the key role of AXL in a broad range of cancers, the results offer major insights into the mechanisms of cancer cell dormancy and therapy resistance.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1101/gad.351985.124

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Oxford Ludwig Institute
Role:
Author
ORCID:
0000-0003-1476-4848
More by this author
Role:
Author
ORCID:
0000-0001-7393-9818
More by this author
Role:
Author
ORCID:
0000-0002-6498-5174
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Oxford Ludwig Institute
Role:
Author
ORCID:
0000-0001-6546-332X


More from this funder
Funder identifier:
https://ror.org/02aqv1x10
Grant:
FP7-PEOPLE: PIEF-GA2013-626098
More from this funder
Funder identifier:
https://ror.org/019w4f821
Grant:
810653
More from this funder
Funder identifier:
https://ror.org/04wfr2810
Grant:
ALTF 800–2013
More from this funder
Funder identifier:
https://ror.org/00snfqn58
Grant:
2021.05801.BD
PTDC/ MED-ONC/5553/2020
More from this funder
Funder identifier:
https://ror.org/003x0zc53
Grant:
MCIN/AEI/10.13039/501100011033
PID2021-127645OA-I00
PID2023-151128OB-I00
PID2019-104867RB-I00


Publisher:
Cold Spring Harbor Laboratory Press
Journal:
Genes & Development More from this journal
Volume:
39
Issue:
7-8
Pages:
463-489
Place of publication:
United States
Publication date:
2025-02-27
Acceptance date:
2025-01-27
DOI:
EISSN:
1549-5477
ISSN:
0890-9369
Pmid:
40015991


Language:
English
Keywords:
Pubs id:
2094049
Local pid:
pubs:2094049
Deposit date:
2025-05-01
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP